Avid Bioservices (CDMO) Reports Q2 EPS of $0.06

Avid Bioservices (NASDAQ: CDMO) reported Q2 EPS of $0.06, versus ($0.08) reported last year. Revenue for the quarter came in at $25.4 million, versus $15.3 million reported last year.

GUIDANCE:

Avid Bioservices sees FY2020 revenue of $76-81 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• Cronos Group replaces broker for Canadian share repurchase program
• Halozyme names David Ramsay as president of drug delivery